SSX1 and synovial sarcoma: In the present mouse synovial sarcoma model, SS18-SSX1 was introduced using a murine myeloid leukemia virus-based retroviral vector, which enabled aberrations of genes cooperating with SS18-SSX1 via retroviral integrations [23,24,25].